MAPT and kidney disorder: However, certain comorbidities, especially kidney disease, can lead to false elevations in plasma p-tau levels32,33, although this can be mitigated by using the ratio of p-tau217 to the non-phosphorylated levels of the same tau peptide (%p-tau217)34.